Lilly’s weight-loss drug Zepbound to face supply crunch through April-end, US FDA says
(Reuters) -Two doses of Eli Lilly’s weight-loss drug Zepbound are expected to remain in short supply through April-end, the U.S.…
U.S. Steel union rejects Nippon Steel’s appeal for takeover support
(Reuters) -The union representing employees of United States Steel on Tuesday said it would not support Japanese firm Nippon Steel’s…
Fed officials see three rate cuts ‘reasonable’ this year
By Ann Saphir and Michael S. Derby (Reuters) -A pair of Federal Reserve policymakers often considered to have divergent monetary…
NATO boss floats 100 billion euro military aid fund for Ukraine
By Andrew Gray and John Irish BRUSSELS (Reuters) – NATO boss Jens Stoltenberg has proposed a 100 billion euro ($107…
Biden administration weighing $18 billion in arms transfers to Israel, sources say
By Humeyra Pamuk, Patricia Zengerle and Matt Spetalnick WASHINGTON (Reuters) – President Joe Biden’s administration is weighing whether to go…
Trump Media shares plummet 21% days after debut
By Yuvraj Malik and Priyanka G (Reuters) -Shares of Donald Trump’s social media company plunged 21% on Monday, wiping out…
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
By Blake Brittain (Reuters) -Teva Pharmaceutical and Viatris convinced a U.S. appeals court on Monday to revive their challenges to…
OpenAI makes ChatGPT’s accessible without requiring sign ups
(Reuters) – OpenAI will start allowing users to access its free-to-use ChatGPT generative AI chatbot without needing to sign up…
Citi says 42% of energy clients lack climate transition plans
By Isla Binnie NEW YORK (Reuters) – Almost half of the energy companies Citi lends to are lacking plans to…
Home Depot bulks up Pro-business with $18.25 billion deal for building products supplier SRS
By Deborah Mary Sophia, Savyata Mishra and Abigail Summerville (Reuters) -Home Depot will buy building materials supplier SRS Distribution in…